What is the long-term trend for Beneficient's trading securities in marketable securities?

Over 3 years (2022 to 2025), Beneficient's trading securities in marketable securities has grown at a 180.6% compound annual growth rate (CAGR), from $1.2M to $26.5M.

Beneficient BENF Trading Securities in Marketable Securities

Trading Securities in Marketable Securities at other companies

Hamilton LaneHLNE

——

LCNBLCNB

——

Community Financial SystemCBU

——

Other financials

Income statement

See full

Revenue$18.7M+322%

Operating income$3.9M+141%

Net income$19.9M+331%

EPS (diluted)-$0.49+26.5%

Balance sheet

See full

Cash & equivalents$7.9M+87.3%

Total debt$100.3M-16.6%

Total equity-$128.6M-1,002%

Total assets$337.9M-15.5%

Cash flow

See full

Operating cash flow-$9.4M+6.3%

CapEx$96.0K-85.5%

Free cash flow-$9.4M+6.7%

Valuation

See full

Market cap$52.86M+2,018%

Enterprise value$145.33M+40.6%

Profitability

See full

Operating margin548.5%-323pp

Net margin517.9%-235pp

FCF margin156.8%-40.4pp

Returns & leverage

See full

Return on equity-1,647.1%-2,080pp

Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's trading securities in marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beneficient's trading securities in marketable securities?: Beneficient (BENF) reported trading securities in marketable securities of $26.5M in Q4 2025.
How has Beneficient's trading securities in marketable securities changed year-over-year?: Beneficient's trading securities in marketable securities decreased by 1.5% year-over-year, from $26.9M to $26.5M.
What is the long-term trend for Beneficient's trading securities in marketable securities?: Over 3 years (2022 to 2025), Beneficient's trading securities in marketable securities has grown at a 180.6% compound annual growth rate (CAGR), from $1.2M to $26.5M.